The Veterans Affairs Diabetes Trial previously showed that intensive glucose lower- ing, as compared with standard therapy, did not significantly reduce the rate of major cardiovascular events among 1791 military veterans (median follow-up, 5.6 years). We report the extended follow-up of the study participants.